CGAP generated a wide range of genomics data on cancerous cells that are accessible through easy-to-use online tools. Researchers, educators, and students can find "in silico" answers to biological questions through the CGAP website. Request a free copy of the CGAP Website Virtual Tour CD from firstname.lastname@example.org to learn how to navigate the website.
Cancer Genome Anatomy Project (CGAP)
Cancer in Children and Adolescents
View a fact sheet that has statistics as well as information about types, causes, and treatments of cancers in children and adolescents in the United States.
Cancer Therapy Evaluation Program
The Cancer Therapy Evaluation Program (CTEP) seeks to improve the lives of cancer patients by finding better treatments, control mechanisms, and cures for cancer. CTEP funds a national program of cancer research, sponsoring clinical trials to evaluate new anti-cancer agents.
Find comprehensive information on childhood cancers: current treatments, clinical trials, prevention, genetics, testing, and more.
Childhood Cancers in Spanish (Español)
Gabriella Miller Kids First (GMKF/Kids First) Pediatric Research Program
The Gabriella Miller Kids First initiative is a trans-NIH effort to increase understanding of genetic changes associated with certain devastating pediatric conditions. The initiative will develop a centralized database of well-curated clinical and genetic sequence data from childhood cancer and structural birth defects cohorts comprising thousands of patients and their families.
To learn more about the initiative and the data available, please visit
Guide to Accessing Program Data
Visit the Guide to Accessing Data page for a visual and interactive guide on how to access OCG program data.
Open versus Controlled-Access Data
OCG employs stringent human subjects’ protection and data access policies to protect the privacy and confidentiality of the research participants. Depending on the risk of patient identification, OCG programs data are available to the scientific community in two tiers: open or controlled access. Both types of data can be accessed through its corresponding OCG program-specific data matrix or portal.
Data within this category presents minimal risk of participant identification. Much of OCG program data, excluding patient identifiers, are open-access. OCG provides the scientific community the maximum amount of open-access data allowable under HIPAA guidelines. Access to these data does not require user certification, and researchers may explore data content without restriction.
Data within this category present a higher risk of patient identification. While stripped of direct patient identifiers as defined by HIPAA, controlled-access data contain specific demographic, clinical, and genotypic information that are excluded in open-access data. Controlled-access data are unique and valuable to research projects for which open-access data are insufficient. Access to protected data requires user certification which can be obtained through NCBI’s dbGaP (National Center for Biotechnology Information’s database of Genotypes and Phenotypes).
To learn more and understand which data each OCG program provides, visit How to Access Multiple Datasets.
TARGET Data Matrix
TARGET Project Experimental Methods
On this page researchers can find detailed information describing how TARGET data was generated by genomic platform, including protocols for establishing high-quality nucleic acid samples.